According to this study, the global Infectious Disease Diagnostics market size will reach US$ 5088 million by 2031.

Infectious disease diagnostics are medical tests and assays used to identify infectious agents, such as bacteria, viruses, and parasites, in patient samples. They play a crucial role in early detection and effective management of infectious diseases.

The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The markets growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.

LPI (LP Information) newest research report, the Infectious Disease Diagnostics Industry Forecast looks at past sales and reviews total world Infectious Disease Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease Diagnostics sales for 2025 through 2031. With Infectious Disease Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Infectious Disease Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Infectious Disease Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Molecular Diagnostic Technique
    Traditional Diagnostic Technique

Segmentation by Application:

    Hepatitis C
    Hepatitis B
    Tuberculosis (TB)
    Acquired Immunodeficiency Syndrome (AIDS)
    Human Papillomavirus (HPV)
    Methicillin-resistant Staphylococcus Aureus (MRSA)

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Bio Mrieux SA
    Roche Diagnostics
    Abbott Laboratories
    Thermo Fischer Scientific
    BD
    Bio-Rad Laboratories
    Abbott
    Danaher
    Johnson and Johnson
    Guangzhou Wondfo Biotech Co.,Ltd.
    Getein Biotech, Inc.
    Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
    BGI Genomics Co.,Ltd.
    Maccura Biotechnology Co.,Ltd.
    Daan Gene
    Beijing Strong Biotechnologies,Inc
    Shanghai Kehua Bio-Engineering Co.,Ltd.
    Guangdong Hybribio Biotech Co.,Ltd.
    Shanghai Runda Medical Technology Co.,Ltd.
    Tellgen Corporation